← back to search

Jose‐Ezequiel Martín

Cambridge University Hospitals NHS Foundation Trust · GB
Area of research
Pathology and Forensic Medicine · Rheumatology
Research interest
Research interests include Biology, Genetics, Medicine, Single-nucleotide polymorphism, Cancer research, and Genome-wide association study.
h-index
citations
1,394
works
24
NIH funding
primary concept
email

Recent publications

Akkermansia muciniphila-induced trained immune phenotype increases bacterial intracellular survival and attenuates inflammation
Communications Biology 2024cited by 37position: middledoi
Inhibition of lung tumorigenesis by transient reprogramming in cancer cells
Cell Death and Disease 2024cited by 4position: middledoi
Abstract 5504: A tumor-promoting senescent secretome triggered by platinum chemotherapy exploits a targetable TGFβR1/Akt-mTOR axis in lung cancer
Cancer Research 2023cited by 0position: middledoi
Failed reprogramming of transformed cells due to induction of apoptosis and senescence impairs tumor progression in lung cancer
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 0position: middledoi
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
Nature Cancer 2022cited by 127position: middledoi
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
British Journal of Cancer 2022cited by 65position: middledoi
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis
Scientific Reports 2022cited by 20position: middledoi
Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
Nature Cancer 2022cited by 7position: middledoi
A tumour-promoting senescent secretome triggered by platinum chemotherapy exploits a targetable TGFβR1/Akt-mTOR axis in lung cancer
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 2position: middledoi
Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort
Clinical Endocrinology 2021cited by 8position: middledoi
Familial wild-type gastrointestinal stromal tumour in association with germline truncating variants in both SDHA and PALB2
European Journal of Human Genetics 2021cited by 4position: middledoi
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal
Nature Medicine 2020cited by 88position: middledoi
SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice
Scientific Reports 2019cited by 24position: middledoi
Basket of baskets (BoB): A modular, open label, phase II, multicenter study to evaluate targeted agents in molecularly selected populations with advanced solid tumors.
Journal of Clinical Oncology 2019cited by 4position: middledoi
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes
The American Journal of Human Genetics 2018cited by 72position: middledoi
Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review
The Journal of Clinical Endocrinology & Metabolism 2017cited by 43position: middledoi
Brief Report: <i>IRF4</i> Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of Genome‐Wide Association Studies
Arthritis & Rheumatology 2016cited by 53position: middledoi
A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility
The American Journal of Human Genetics 2015cited by 176position: middledoi
Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis
The American Journal of Human Genetics 2014cited by 206position: middledoi
The IRF5–TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share
Human Molecular Genetics 2014cited by 89position: middledoi
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci
Human Molecular Genetics 2013cited by 106position: firstdoi
The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis
PLoS ONE 2013cited by 98position: middledoi
Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up
Human Molecular Genetics 2012cited by 96position: firstdoi
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
Annals of the Rheumatic Diseases 2012cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ruth Casey · Imperial College Healthcare NHS Trust4 papers (2017–2021)David Macías · Universidad de Sevilla4 papers (2022–2024)Mary Denholm · Cambridge University Hospitals NHS Foundation Trust4 papers (2022–2024)Daniel Muñoz‐Espín · University of Cambridge4 papers (2022–2024)Philip Smith · Cancer Research UK Cambridge Center3 papers (2017–2021)Soo‐Mi Park · Cambridge University Hospitals NHS Foundation Trust3 papers (2017–2021)Eamonn R. Maher · Aston Medical (France)3 papers (2017–2021)Olivier Giger · Cambridge University Hospitals NHS Foundation Trust3 papers (2017–2021)Graeme R. Clark · Cambridge University Hospitals NHS Foundation Trust3 papers (2017–2021)Fay Rodger · Cancer Research UK Cambridge Center3 papers (2017–2021)Thomas M. Roberts · University of London2 papers (2017–2019)Ioana Olan · Cancer Research UK Cambridge Center2 papers (2022–2023)Guillermo Medrano · Houston Methodist2 papers (2022–2023)Sabela Da Silva‐Álvarez · Universidade de Santiago de Compostela2 papers (2023–2024)Pablo Pedrosa · Universidade de Santiago de Compostela2 papers (2023–2024)James E. Korkola · Oregon Health & Science University2 papers (2022–2023)Gary J. Doherty · GeneCare Research Institute (Japan)2 papers (2022–2023) · 2 papers (2022–2023)Dimitris Veroutis · University of Dundee2 papers (2022–2023)Samir Morsli · University of Cambridge2 papers (2022–2023)